Study finds new therapeutic targets for neurodegenerative disease
Drug Discovery World
SEPTEMBER 29, 2023
AI-driven drug discovery company Insilico Medicine and the University of Cambridge have discovered an approach to identify therapeutic targets for human diseases associated with protein phase separation (PPS). By working with Insilico Medicine, we have provided a roadmap for researchers to navigate this complex terrain.”
Let's personalize your content